CHARLES HENSLEIGH: Open Payments
NPI 1528051133 · ASHLAND, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 56 payments from 14 companies in 2025. Trend: 2023 $1,110 · 2024 $894 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $215 |
| PFIZER INC. | 14 | $146 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
| ABBVIE INC. | 5 | $94 |
| Exact Sciences Corporation | 5 | $94 |
| Amgen Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: ELIQUIS, Wegovy, Cologuard Collection Kit, Ozempic, FARXIGA, Kerendia, Rybelsus, JARDIANCE.
Industry payments across AL — which companies pay providers there.
